Genetics of Parkinson disease: paradigm shifts and future prospects
Top Cited Papers
- 1 April 2006
- journal article
- review article
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 7 (4), 306-318
- https://doi.org/10.1038/nrg1831
Abstract
Parkinson disease is a complex, multifactorial neurodegenerative disease. Although a heritable basis was originally thought unlikely, recent studies have implicated several genes in its pathogenesis, and molecular findings now allow accurate diagnosis and challenge past criteria for defining Parkinson disease. Most importantly, genetic insights provide the rationale for new strategies for prevention or therapy, and have led to animal models of disease in which these strategies can be tested. Neuroprotective therapies can now be designed to slow or halt disease progression in affected subjects and asymptomatic carriers.Keywords
This publication has 132 references indexed in Scilit:
- Lrrk2 pathogenic substitutions in Parkinson's diseaseneurogenetics, 2005
- Dopaminergic function in a family with the PARK6 form of autosomal recessive Parkinson’s syndromeJournal of Neural Transmission, 2005
- α-synuclein locus duplication as a cause of familial Parkinson's diseaseThe Lancet, 2004
- Causes of Parkinson?s disease: genetics of DJ-1Cell and tissue research, 2004
- Parkin genetics: one model for Parkinson's diseaseHuman Molecular Genetics, 2004
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- Dementia with Lewy bodiesSeminars in Clinical Neuropsychiatry, 2003
- Phosphorylation of α-synuclein characteristic of synucleinopathy lesions is recapitulated in α-synuclein transgenic DrosophilaNeuroscience Letters, 2002
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998